Clinical Trials Insight: 700028288
Phase of Trial: Phase I
Latest Information Update: 04 Mar 2011
At a glance
- Drugs RH 1 (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- Sponsors Allos Therapeutics
- 04 Mar 2011 Results have been published in Annals of oncology: official journal of the European Society for Medical Oncology.
- 04 Mar 2011 Status changed from not yet recruiting to completed.
- 16 Nov 2007 Status change